Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Genenta Science S.p.A. Unsponsored ADR (GNTA) Stock-Based Compensation data is not available for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$33.92M |
|
$0.17M |
|
$2.30M |
|
$36.08M |
|
$2.40M |
|
$8.60M |
|
$8.97M |
|
$11.37M |
|
$24.71M |
|
$24.71M |
|
$24.71M |
|
-- |
|
| Cash Flow Statement Financials | |
$-7.77M |
|
$-16.45M |
|
$25.22M |
|
$5.18M |
|
$6.25M |
|
$1.07M |
|
|
Stock-Based Compensation |
-- |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|